T

The Ohio State Comprehensive Cancer Center | Division of Hematology

Research site
(Unclaimed)
Location
460 W 10th Avenue, Columbus, Ohio, United States of America
Site insights

Top conditions

COVID-19 (1 trial)

Hematologic Cancer (1 trial)

Carcinoma (1 trial)

Serous Cystadenocarcinoma (1 trial)

Preleukemia (1 trial)

Top treatments

TL-895
Ribociclib
Letrozole
Imetelstat

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

2 of 3
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
Ribociclib and Letrozole Treatment in Ovarian Cancer

The study evaluates the response to treatment with Ribociclib and Letrozole in patients with low grade serous cancer of the ovary, fallopian tube or...

Active, not recruiting
Low Grade Serous Carcinoma
Drug: Ribociclib
Drug: Letrozole

The purpose of this study is to evaluate the efficacy and safety of imetelstat in transfusion-dependent participants with low or intermediate-1 risk...

Active, not recruiting
Myelodysplastic Syndromes
Drug: Imetelstat
Drug: Placebo

Trial sponsors

G

Geron (1 trial)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems